beta-cells
发表于 2025-3-30 08:11:49
Response-Related Predictors of Survival and of Treatment-Free Remission in CML,dvanced-phase disease. Treatment failure mandates a switch in therapy, usually to a more potent TKI, if possible. In between optimal response and treatment failure, there is a “warning category” where outcomes are generally inferior and therapeutic decisions are more complex. Recently, the importanc
竞选运动
发表于 2025-3-30 12:38:02
Book 2021Latest editions of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the impact of availability of generic imatinib. .
衰老
发表于 2025-3-30 18:08:03
https://doi.org/10.1007/978-3-030-71913-5Chronic myeloid leukaemia; BCR-ABL; Tyrosine kinase inhibitors; Philadelphia chromosome; Fertility; Hemat
美学
发表于 2025-3-30 21:40:08
http://reply.papertrans.cn/23/2264/226397/226397_54.png
使害羞
发表于 2025-3-31 01:09:39
http://reply.papertrans.cn/23/2264/226397/226397_55.png
Fecundity
发表于 2025-3-31 06:09:49
http://reply.papertrans.cn/23/2264/226397/226397_56.png
Affluence
发表于 2025-3-31 09:21:13
https://doi.org/10.1007/978-3-663-11257-0r epidemiological research. CML registries with a more comprehensive reporting may also provide complementary data on treatment outcome to those obtained from clinical trials. Reports from several European CML registries consistently show a crude annual incidence of 0.7–1.3/100,000, median age at di
Dysarthria
发表于 2025-3-31 15:56:57
http://reply.papertrans.cn/23/2264/226397/226397_58.png
鸟笼
发表于 2025-3-31 17:35:50
http://reply.papertrans.cn/23/2264/226397/226397_59.png
originality
发表于 2025-4-1 00:22:35
http://reply.papertrans.cn/23/2264/226397/226397_60.png